Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
Data suggest that most patients who use medical aid in dying (MAID) have cancer, but some oncology providers do not feel well informed about MAID.
NCCN has updated its recommendations on COVID-19 vaccination to include advice about bivalent vaccines, vaccinating immunocompromised children, and more.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Acupuncture and moxibustion, which are sometimes used together, have shown promise in reducing insomnia in patients with cancer.
Anticancer drugs approved by the FDA in the last 2 decades provide modest improvements in survival, according to new research.
Many clinical trials supporting cancer drug approvals are ineligible for individual participant data sharing, a new study suggests.
As the COVID-19 pandemic wears on, oncology professionals must decide if attending conferences in person is worth the risks.
Researchers sought to determine the incidence, nature, and consequences of oncologists’ experiences with workplace sexual harassment.